#METABOLOMICS WORKBENCH japizsaab_20220805_152657 DATATRACK_ID:3390 STUDY_ID:ST002527 ANALYSIS_ID:AN004161 PROJECT_ID:PR001627
VERSION             	1
CREATED_ON             	March 28, 2023, 10:05 am
#PROJECT
PR:PROJECT_TITLE                 	Pancreatic tumors activate arginine biosynthesis to adapt to myeloid-driven
PR:PROJECT_TITLE                 	amino acid stress
PR:PROJECT_SUMMARY               	Nutrient stress in the tumor microenvironment requires cancer cells to adopt
PR:PROJECT_SUMMARY               	adaptive metabolic programs to maintain survival and proliferation. Therefore,
PR:PROJECT_SUMMARY               	knowledge of microenvironmental nutrient levels and how cancer cells cope with
PR:PROJECT_SUMMARY               	such nutrition is critical to understand the metabolism underpinning cancer cell
PR:PROJECT_SUMMARY               	biology. Previously, we performed quantitative metabolomics of the interstitial
PR:PROJECT_SUMMARY               	fluid (the local perfusate) of murine pancreatic ductal adenocarcinoma (PDAC)
PR:PROJECT_SUMMARY               	tumors to comprehensively characterize nutrient availability in the
PR:PROJECT_SUMMARY               	microenvironment of these tumors (Sullivan et al., 2019a). Here, we develop
PR:PROJECT_SUMMARY               	Tumor Interstitial Fluid Medium (TIFM), a cell culture medium that contains
PR:PROJECT_SUMMARY               	nutrient levels representative of the PDAC microenvironment, enabling study of
PR:PROJECT_SUMMARY               	PDAC metabolism under physiological nutrition. We show that PDAC cells cultured
PR:PROJECT_SUMMARY               	in TIFM, compared to standard laboratory models, adopt a cellular state more
PR:PROJECT_SUMMARY               	similar to PDAC cells in tumors. Further, using the TIFM model we identified
PR:PROJECT_SUMMARY               	arginine biosynthesis as a metabolic adaptation PDAC cells engage to cope with
PR:PROJECT_SUMMARY               	microenvironmental arginine starvation driven by myeloid cells in PDAC tumors.
PR:PROJECT_SUMMARY               	Altogether, these data show that nutrient availability in tumors is an important
PR:PROJECT_SUMMARY               	determinant of cancer cell metabolism and behavior, and cell culture models that
PR:PROJECT_SUMMARY               	incorporate physiological nutrient availability have improved fidelity and
PR:PROJECT_SUMMARY               	enable the discovery of novel cancer metabolic phenotypes.
PR:INSTITUTE                     	University of Chicago
PR:LAST_NAME                     	Apiz Saab
PR:FIRST_NAME                    	Juan
PR:ADDRESS                       	929 E. 57th St.
PR:EMAIL                         	japizsaab@uchicago.edu
PR:PHONE                         	7738346506
#STUDY
ST:STUDY_TITLE                   	HPLC-MS-MS analysis amino acid levels in PDAC IF samples upon arginase
ST:STUDY_TITLE                   	inhibition
ST:STUDY_SUMMARY                 	To test the hypothesis that myeloid arginase-1 activity could be responsible for
ST:STUDY_SUMMARY                 	pancreatic ductal adenocarninoma microenvironmental arginine starvation (PMID:
ST:STUDY_SUMMARY                 	30990168), we generated orthotopic allograft mPDAC tumors in a mouse model with
ST:STUDY_SUMMARY                 	myeloid specific Arg1 knockout (LysM-Cre+/+-; Arg1fl/fl) and control animals
ST:STUDY_SUMMARY                 	(Arg1fl/fl). We also tested this with pharmacological inhibition of arginase-1
ST:STUDY_SUMMARY                 	with the small-molecule inhibitor CB-1158. We then isolated IF from these tumors
ST:STUDY_SUMMARY                 	at end-stage and measured the levels of amino acids including arginine and
ST:STUDY_SUMMARY                 	ornithine in these samples.
ST:INSTITUTE                     	University of Chicago
ST:LAST_NAME                     	Apiz Saab
ST:FIRST_NAME                    	Juan
ST:ADDRESS                       	929 E. 57th St.
ST:EMAIL                         	japizsaab@uchicago.edu
ST:PHONE                         	7738346506
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	T245	Genotype:NA | Treatment:CB1158	RAW_FILE_NAME=Mui-Lin-20210408-02-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T244	Genotype:NA | Treatment:CB1158	RAW_FILE_NAME=Mui-Lin-20210408-04-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T241	Genotype:NA | Treatment:CB1158	RAW_FILE_NAME=Mui-Lin-20210408-06-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T242	Genotype:NA | Treatment:CB1158	RAW_FILE_NAME=Mui-Lin-20210408-08-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T231	Genotype:NA | Treatment:CB1158	RAW_FILE_NAME=Mui-Lin-20210408-33-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T278	Genotype:NA | Treatment:Vehicle	RAW_FILE_NAME=Mui-Lin-20210408-01-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T238	Genotype:NA | Treatment:Vehicle	RAW_FILE_NAME=Mui-Lin-20210408-03-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T282	Genotype:NA | Treatment:Vehicle	RAW_FILE_NAME=Mui-Lin-20210408-05-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T400	Genotype:NA | Treatment:Vehicle	RAW_FILE_NAME=Mui-Lin-20210408-07-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T239	Genotype:NA | Treatment:Vehicle	RAW_FILE_NAME=Mui-Lin-20210408-09-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T234	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-10-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T214	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-30-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T203	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-23-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T236	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-25-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T215	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-28-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T298	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-29-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T233	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-34-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T111	Genotype:Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-24-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T202	Genotype:Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-27-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T237	Genotype:Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-31-2.raw
SUBJECT_SAMPLE_FACTORS           	-	T217	Genotype:Arg1fl/fl | Treatment:NA	RAW_FILE_NAME=Mui-Lin-20210408-32-2.raw
#COLLECTION
CO:COLLECTION_SUMMARY            	Tumors were rapidly dissected after euthanizing animals. Tumors were weighed and
CO:COLLECTION_SUMMARY            	rinsed in blood bank saline solution (150 mM NaCl) and blotted on filter paper
CO:COLLECTION_SUMMARY            	(VWR, Radnor, PA, 28298–020). The process of dissection and tumor preparation
CO:COLLECTION_SUMMARY            	took < 3min. Tumors were cut in half and put onto 20µm nylon mesh filters
CO:COLLECTION_SUMMARY            	(Spectrum Labs, Waltham, MA, 148134) on top of 50 mL conical tubes, and
CO:COLLECTION_SUMMARY            	centrifuged for 10min. at 4°C at 400xg. IF was then collected, snap-frozen in
CO:COLLECTION_SUMMARY            	liquid nitrogen and stored at -80°C until further analysis.
CO:SAMPLE_TYPE                   	Interstitial Fluid
#TREATMENT
TR:TREATMENT_SUMMARY             	For genetically modified mice, LysM-Cre and Arg1fl/fl C57BL6J mice were bred to
TR:TREATMENT_SUMMARY             	generate LysM-Cre +/+; Arg1fl/fl and litter mate control Arg1fl/fl mice.
TR:TREATMENT_SUMMARY             	Orthotopic pancreatic cancer tumors were implanted in C57BL6J mice at 8-12 weeks
TR:TREATMENT_SUMMARY             	of age. At endpoint, mice were euthanized by cervical dislocation, and tumors
TR:TREATMENT_SUMMARY             	were harvested for TIF extraction. For Pharmacological inhibition, orthotopic
TR:TREATMENT_SUMMARY             	tumors were implanted in C57BL6J mice at 8-12 weeks of age. 4 weeks after
TR:TREATMENT_SUMMARY             	induction, once tumors were close end stage disease, CB-1158 (MedChem Express)
TR:TREATMENT_SUMMARY             	dissolved in sterile water was administered by oral gavage at 100mg/kg. The
TR:TREATMENT_SUMMARY             	acidity caused by the HCl in the drug solution was neutralized by adding
TR:TREATMENT_SUMMARY             	equivalent amount of NaOH and an equivalent NaCl in sterile water solution was
TR:TREATMENT_SUMMARY             	prepared as vehicle. 2hrs after treatment with CB-1158 or vehicle, mice were
TR:TREATMENT_SUMMARY             	euthanized by cervical dislocation, and tumors were harvested for TIF
TR:TREATMENT_SUMMARY             	extraction.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	polar metabolites were extracted from 5µL IF samples using 45µL 75:25:0.1 HPLC
SP:SAMPLEPREP_SUMMARY            	grade acetonitrile:methanol:formic acid extraction mix into which a mixture of
SP:SAMPLEPREP_SUMMARY            	isotopically labeled amino acids of known concentrations (Cambridge Isotope
SP:SAMPLEPREP_SUMMARY            	Laboratories, MSK-A2-1.2) was added. Samples were vortexed for 10 min, and
SP:SAMPLEPREP_SUMMARY            	centrifuged at maximum speed for 10 min. 30 μL of each extract was removed and
SP:SAMPLEPREP_SUMMARY            	dried under nitrogen gas and stored −80°C.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	HILIC
CH:INSTRUMENT_NAME               	Thermo Dionex Ultimate 3000
CH:COLUMN_NAME                   	Waters XBridge Amide (100 x 4.6mm,3.5um)
CH:SOLVENT_A                     	95% (vol/vol) water, 5% (vol/vol) acetonitrile, 10 mM ammonium hydroxide, 10 mM
CH:SOLVENT_A                     	ammonium acetate, pH = 9.0
CH:SOLVENT_B                     	100% Acetonitrile
CH:FLOW_GRADIENT                 	0 min, 15% A; 2.5 min, 64% A; 12.4 min, 40% A; 12.5 min, 30% A; 12.5-14 min, 30%
CH:FLOW_GRADIENT                 	A; 14-21 min, 15% A
CH:FLOW_RATE                     	150 μL/min
CH:COLUMN_TEMPERATURE            	25
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	UNSPECIFIED
MS:MS_COMMENTS                   	In positive/negative polarity switching mode, an m/z scan range from 60 to 900
MS:MS_COMMENTS                   	was chosen and MS1 data was collected at a resolution of 70,000. The automatic
MS:MS_COMMENTS                   	gain control (AGC) target was set at 1 × 106 and the maximum injection time was
MS:MS_COMMENTS                   	200 ms. The targeted ions were subsequently fragmented, using the higher
MS:MS_COMMENTS                   	energy collisional dissociation (HCD) cell set to 30% normalized collision
MS:MS_COMMENTS                   	energy in MS2 at a resolution power of 17,500. Besides matching m/z, target
MS:MS_COMMENTS                   	metabolites are identified by matching either retention time with analytical
MS:MS_COMMENTS                   	standards and/or MS2 fragmentation pattern. Data acquisition and analysis were
MS:MS_COMMENTS                   	carried out by Xcalibur 4.1 software and Tracefinder 4.1 software, respectively
MS:MS_COMMENTS                   	(both from Thermo Fisher Scientific).
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	Peak area (m/z)
MS_METABOLITE_DATA_START
Samples	T278	T245	T238	T244	T282	T241	T400	T242	T239	T234	T203	T111	T236	T202	T215	T298	T214	T237	T217	T231	T233
Factors	Genotype:NA | Treatment:Vehicle	Genotype:NA | Treatment:CB1158	Genotype:NA | Treatment:Vehicle	Genotype:NA | Treatment:CB1158	Genotype:NA | Treatment:Vehicle	Genotype:NA | Treatment:CB1158	Genotype:NA | Treatment:Vehicle	Genotype:NA | Treatment:CB1158	Genotype:NA | Treatment:Vehicle	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	Genotype:Arg1fl/fl | Treatment:NA	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	Genotype:Arg1fl/fl | Treatment:NA	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA	Genotype:Arg1fl/fl | Treatment:NA	Genotype:Arg1fl/fl | Treatment:NA	Genotype:NA | Treatment:CB1158	Genotype:LysM-Cre+/+; Arg1fl/fl | Treatment:NA
alanine	523882213	665366442	553355746	659426901	855120451	683908395	720401203	811402985	596203035	1030701024	1064349344	595038393	868296015	1207982150	685347221	816675164	522068620	603741202	756460459	757752305	953702346
alanine_13C3_15N	69444297	121026475	92751805	117597621	117476696	126949939	113590585	124493375	101535044	111900612	98340772	103612981	91253941	99587109	111175217	91535427	46896091	117799638	93160154	101514396	90772111
arginine	15340384	509477213	15963464	448670179	44070934	696484257	303242696	485936625	77999505	852856228	902790825	21933398	846566956	418282234	901672616	940740561	345309030	30916052	17567574	39064591	789413918
arginine_13C6_15N4	706974619	1429784641	1132933084	1199365402	1322819866	1378726057	1242799318	1264095985	1074413296	1041782009	1007811620	1071493892	863984865	1131312438	1067893988	813697156	407899696	1174649819	822954194	1060947605	908468868
aspartic acid	254788767	218634105	230325424	358848958	245178714	291241713	193027292	354647087	494417951	592926273	856042597	411280238	371268591	793994914	382494001	596844261	520963586	345515529	558556008	577551365	826085193
aspartic acid_13C4_15N	54229900	53794414	69040857	65801128	71426321	76315972	82266092	91842409	91407961	84619374	106556099	116994749	99447919	109348747	108163057	99296601	63022828	107076488	94254069	108528709	112941511
citrulline	55871932	29410641	54428610	41575757	56707942	43066219	73939072	50142728	75197723	96428149	122261165	100433915	163589561	124525152	135188307	179648859	139503479	132171268	124775827	143139516	140653201
citrulline_13C5	560411090	465568905	637520284	565469074	633329215	604233533	700218353	693677878	767840460	686817792	900839473	1188608663	1183661206	1040862386	1299168219	1211403944	1075223383	1687433573	1315583245	1261980165	1010161149
cystine	5356958	4647092	3763879	5379871	7101641	10970674	7050325	7599334	4491406	4298805	279455	6699636	2408775	2567491	5216990	4691150	2598554	1956840	5801144	2481165	1153881
cystine_13C6_15N2	7321265	10331815	8020501	9103151	8453714	9942144	7687599	7876234	7082849	5784516	4833916	5678798	5062870	4793232	5082532	4241024	2267928	5983144	4117765	4070646	2658445
glutamic acid	1107396968	1280321186	1152785862	1350888795	1094317187	1230369405	979933376	1418571862	1329095089	1729172619	1960935093	1083229104	1181242183	1928478064	1174231526	1277827839	976715048	908308737	1205186985	1261827361	1803091610
glutamic acid_13C5_15N	101603642	144488619	135878426	134251602	134620922	147562177	162349643	160460589	128308808	123556208	103530454	126449216	108885588	103445784	128776672	96052809	54211955	134085224	100629170	116441195	104144761
glycine	197994169	290848314	230333923	328864536	256881737	305004116	307732749	371705708	357183086	586692237	592746348	263504115	278710501	466066675	284691688	395800791	344438394	274460954	360446999	361927672	524736536
glycine_13C2_15N	37848110	63526592	51565373	57957822	52187872	59458847	59000656	62815113	50586044	52247948	45252136	50139503	45005392	46446157	55051041	43021577	25688791	60875725	43745023	49714086	45704051
histidine	143681431	100762317	163989976	114134595	156504931	138422665	209737160	151375524	164326379	208934198	432969277	439214786	490594125	490482695	507247821	490445989	439844244	492919265	433382708	535761667	395721989
histidine_13C6_15N3	154924402	131022286	171157245	153500179	170879212	184373608	208001923	190266659	219963303	184819124	416359625	517486803	473052341	441920042	524645023	479076591	376958016	720005922	477289783	531467594	374930029
lysine	599020398	889287351	850866765	753268994	1099507577	844543145	1053961046	720013605	638197267	771478489	558321484	735641476	615972102	937901226	922388423	644167810	333460576	662295469	557172878	866361612	692760257
lysine_13C6_15N2	229382409	454039178	347025278	406756393	395823755	454422313	397990810	416370683	350389129	357008628	338831096	328552540	291735404	363452867	359736319	287830147	150877594	375883675	270743258	376135487	317559472
methionine	259719150	343500193	391370623	312556785	560894477	425575258	577366548	447294356	329858652	648268972	493236529	353482928	557923616	681197733	493416454	576801119	197477407	540282191	342851057	652198568	400248967
methionine_13C5_15N	461969136	851758798	700130234	831353163	815643951	878650097	772495142	826633064	705702735	835967885	760060777	794769438	787991168	895759291	882820610	728477236	359260597	955268513	698774174	790608522	786620323
ornithine	246638195	368608046	344633432	320366816	520033523	497448736	443303858	424975832	294889136	213207447	110343431	318171255	155737275	379101601	204601614	138302802	61451324	293990744	239505867	395350334	142431552
ornithine_13C5_15N2	3259039860	6449344416	5097888885	5641227533	6092477903	6717172996	5628841379	6257266246	5108721046	4866226712	4531488368	4913379074	3961907035	4979794268	4971953680	4358008105	2107771269	5279343718	3984258015	4945883421	4185480921
phenylalanine	481063815	619653047	816117574	676611838	753463567	658273338	776675162	627838935	446843738	866173051	636087991	667670645	1226832222	1048374046	900342785	813873969	397895669	873842720	572242459	983666985	755194547
phenylalanine_13C9_15N	674632629	1144814058	1079020231	1176253221	1058133706	1149717206	1068190705	1034154803	1050736995	1114993388	950221749	1009666587	1041716717	1097408843	1146608429	938170901	488658318	1352740754	889074964	1092759213	930319961
proline	1539070312	2024281834	2089896459	1893168193	2510895879	2034279972	2263437358	2589289942	1730662510	3792062760	3113572337	2181254993	3250435361	3776112969	2462875049	2818341949	1497235151	2451749225	2290957550	2690030074	2603121989
proline_13C5_15N	851487273	1715048635	1383417421	1520787006	1502133218	1575203467	1294506206	1565234496	1290530871	1497881583	1256201202	1366733889	1260290311	1249040436	1475517155	1127802397	665083564	1644617394	1119093489	1265265220	1057990747
serine	74192789	56920384	76994820	74275118	85182186	68078823	90130405	91421481	86856922	128367637	156938846	92544491	141744813	158942604	111111435	126574735	101289459	113733767	107684073	132603230	136274951
serine_13C3_15N	63525403	59696331	75417215	72415486	76256971	75049490	76771182	85732363	82137915	78685261	87305921	92815343	85498977	87068366	98150371	77472975	45981687	116664933	84756007	90053654	84902177
threonine_13C4_15N	179581416	285715922	217928682	253247466	243474699	273099406	270499379	267698711	230556505	221609342	175215792	220768025	201809317	192431302	243574396	197410680	103621613	261755716	195877961	200184325	172712676
tryptophan	216994791	303231125	343047027	353496774	340597676	401508527	281716102	308339384	274396429	392044589	346625413	297428121	398630838	430936044	279960655	307589430	147538809	246935993	222817919	293504194	341369823
tyrosine	150409617	196790303	232004348	177540543	245265482	221486944	294516756	237292820	164522997	277624919	210613525	174772362	391303162	279271800	256597945	255830778	138672286	241238349	152694265	329513176	226189112
tyrosine_13C9_15N	270374403	472737416	380382330	429670558	376964675	429723918	385885497	428387458	375482051	398246992	348177501	386398316	352341182	371228552	434357576	320797828	195868215	400893682	316216948	372369212	334477001
valine	451721379	637144368	623678862	666322623	614348743	578157575	665016681	611980158	419937829	1026131146	627650668	591857445	738986109	857053599	757004829	672482744	449938234	734438928	562337709	1023647891	757782676
valine_13C5_15N	258360853	467474662	377353367	427291938	385873177	469401707	383578388	431614870	369559787	433427360	314977884	395950441	344847179	376660648	410687924	315284580	185073526	433850799	345573325	404641262	355715375
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name
alanine
alanine_13C3_15N
arginine
arginine_13C6_15N4
aspartic acid
aspartic acid_13C4_15N
citrulline
citrulline_13C5
cystine
cystine_13C6_15N2
glutamic acid
glutamic acid_13C5_15N
glycine
glycine_13C2_15N
histidine
histidine_13C6_15N3
lysine
lysine_13C6_15N2
methionine
methionine_13C5_15N
ornithine
ornithine_13C5_15N2
phenylalanine
phenylalanine_13C9_15N
proline
proline_13C5_15N
serine
serine_13C3_15N
threonine_13C4_15N
tryptophan
tyrosine
tyrosine_13C9_15N
valine
valine_13C5_15N
METABOLITES_END
#END